Zinc Oxide Cream for Sacral Pressure Ulcers
Zinc oxide cream is NOT recommended as a primary treatment for established sacral pressure ulcers based on current evidence-based guidelines, though it may have a role in prevention and early-stage wounds.
Primary Recommendation Based on Guidelines
The American College of Physicians 2015 guidelines 111 make no mention of zinc oxide in their evidence-based recommendations for treating pressure ulcers. Instead, the guideline explicitly recommends:
- Hydrocolloid or foam dressings to reduce wound size (weak recommendation, low-quality evidence)
- Protein or amino acid supplementation to reduce wound size (weak recommendation, low-quality evidence)
- Electrical stimulation as adjunctive therapy to accelerate healing (weak recommendation, moderate-quality evidence)
The guideline found that hydrocolloid dressings were superior to gauze dressings for reducing wound size 11, making these the evidence-based first-line local treatment option.
Where Zinc Oxide May Have a Role
For Prevention (Not Treatment)
Recent research suggests zinc oxide may be effective for preventing sacral pressure injuries rather than treating established ulcers:
- A 2024 study 2 found that zinc oxide as a prophylactic dressing prevented pressure injuries in ICU patients (zero cases in the zinc oxide dressing group versus 14 cases in controls, p<0.05)
- A 2023 retrospective study 3 showed zinc oxide cream had better outcomes than barrier creams for maintaining skin integrity in at-risk ICU patients
For Early-Stage Ulcers Only
One 2025 pilot trial 4 showed 25% zinc oxide cream promoted healing in stage I and II pressure ulcers only, with 83% achieving partial healing by day 14 versus 60% with silver dressings. However, this is a single small pilot study that cannot override established guideline recommendations.
Historical Context
A 1985 randomized trial 5 found zinc oxide equivalent to enzymatic debridement for necrotic pressure ulcers (50% vs 43% necrosis removal), but this does not demonstrate superiority over current standard treatments.
Appropriate Ordering Protocol
If you choose to use zinc oxide despite limited guideline support:
Application Instructions (per FDA labeling 6):
- Cleanse the wound area and allow to dry completely
- Apply ointment liberally to the affected area
- Reapply with each dressing change
- Standard concentration is 20% 6
Safety Considerations (per FDA 6):
- For external use only
- Avoid contact with eyes
- Discontinue if condition worsens or fails to improve within 7 days
- Monitor for skin irritation, inflammation, or maceration (the most common harms reported for topical therapies 11)
Clinical Algorithm for Sacral Pressure Ulcers
For established sacral wounds, follow this evidence-based approach:
- First-line local treatment: Hydrocolloid or foam dressing 1
- Nutritional support: Protein/amino acid supplementation if nutritionally deficient 11
- Adjunctive therapy: Consider electrical stimulation to accelerate healing 1
- Support surface: Air-fluidized bed if available (superior to standard beds) 1
- Pressure relief: Frequent repositioning (fundamental to all treatment)
Reserve zinc oxide for:
- Prevention in high-risk patients
- Stage I-II ulcers as an alternative when standard dressings are unavailable or cost-prohibitive
- Peri-wound skin protection
Critical Pitfalls to Avoid
- Do not substitute zinc oxide for evidence-based dressings in stage III-IV ulcers
- Do not use zinc oxide as monotherapy without addressing underlying pressure, nutrition, and support surfaces
- Monitor closely for lack of improvement within 7 days and escalate care 6
- Sacral ulcers have better surgical outcomes than ischial ulcers if surgery becomes necessary 11
The evidence strongly favors hydrocolloid/foam dressings over zinc oxide for treating established sacral pressure ulcers, with zinc oxide relegated to a preventive or adjunctive role at best.